Mold Control and Detection in Biological Drug Substance Manufacturing Facilities: An Industry Perspective

Reference

1. 1.↵
   1. Marshall V.,
   2. Poulson-Cook S.,
   3. Moldenhauer J.

   Comparative Mold and Yeast Recovery Analysis (The Effect of Differing Incubation Temperature Ranges and Growth Media). PDA J. Pharm. Sci. Technol. 1998, 52 (4), 165–169.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Gordon O.,
   2. Berchtold M.,
   3. Staerk A.,
   4. Roesti D.

   Comparison of Different Incubation Conditions for Microbiological Environmental Monitoring. PDA J. Pharm. Sci. Technol. 2014, 68 (5), 394–406.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Bain D.,
   2. Hardy D.,
   3. Bell B. L.,
   4. Forng R. Y.,
   5. Knight M.,
   6. Bawa A.,
   7. Ramsey S.,
   8. Arbesser-Rastburg C.,
   9. Paul M.,
   10. Ton C.,
   11. Leira F.,
   12. Roman C.,
   13. McFarland K.,
   14. Phillips D.,
   15. Stuckey J.,
   16. Bauer C.,
   17. Calvo A. J.

   Microbial Monitoring for Biological Drug Substance Manufacturing: An Industry Perspective. PDA J. Pharm. Sci. Technol. 2015, 69 (3), 451–460.

   OpenUrlFREE Full Text